Background: |
EEA1 is an early endosomal marker and a Rab5 effector protein essential for early endosomal membrane fusion and trafficking. The carboxy terminus of EEA1 contains a FYVE domain which binds to phosphatidylinositol-3-phosphate (PtdIns(3)P), targeting EEA1 to early endosomes. The stable association of EEA1 with the endosomal membrane is regulated by PI3 kinase, Rab5 and calcium/calmodulin. Once on the membrane, EEA1 interacts with Rab5, NSF and syntaxin 13 to promote early endosomal membrane docking and fusion. |
Applications: |
ELISA, WB |
Name of antibody: |
EEA1 |
Immunogen: |
Synthetic peptide of human EEA1 |
Full name: |
early endosome antigen 1 |
Synonyms: |
MST105; ZFYVE2; MSTP105 |
SwissProt: |
Q15075 |
ELISA Recommended dilution: |
5000-10000 |
WB Predicted band size: |
163 kDa |
WB Positive control: |
Hela, 293T, RAW264.7 and NIH/3T3 cell lysates |
WB Recommended dilution: |
200-1000 |